SALT LAKE CITY, June 7, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), the leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, announced today that Douglas C. Robinson, the Company's President and Chief Executive Officer, will be presenting at the Accredited Members Summer 2012 Small Cap/Micro Cap Investment Conference, to be held on June 14 - 15, 2012, at the Denver Marriott City Center in Denver, Colorado.
The LifeVantage Corporation investor presentation is scheduled for Thursday, June 14, 2012, at 9:00 am Mountain Time.
About LifeVantage Corporation
LifeVantage, (OTCBB:LFVN), the leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, is a science based nutraceutical company. LifeVantage is dedicated to visionary science that looks to transform wellness and anti-aging internally and externally with products that dramatically reduce oxidative stress at the cellular level. The Company was founded in 2003 and has its corporate headquarters in Salt Lake City, UT. For more information, visit www.LifeVantage.com
.
The LifeVantage Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=11617
CONTACT: Investor Relations Contact:
Cindy England 801.432.9036
Director of Investor Relations
-or-
John Mills 310.954.1105
Senior Managing Director, ICR, LLC
Source:
LifeVantage Corporation
News Provided by Acquire Media